BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids

Rheumatology (Oxford). 2016 Sep;55(9):1693-7. doi: 10.1093/rheumatology/kev404. Epub 2016 Jan 10.

¹ Centre for Rheumatology Research, UCL Division of Medicine, University College London, London.
² Department of Rheumatology, University Hospitals of Leicester, Leicester.
³ Womens Health, University College London Hospital, London.
⁴ Obstetrics and Gynaecology, Frimley Park Hospital, Surrey.
⁵ Department of Rheumatology, University Hospital Birmingham NHS Foundation Trust, Birmingham.
⁶ Department of Rheumatology, Guy's and St Thomas' NHS Foundation Trust, London, UK, Department of Rheumatology, Copenhagen University Hospital, Rigshospitalet, Denmark.
⁷ Department of Rheumatology, Burton Hospitals NHS Trust, Burton-upon-Trent.
⁸ Rheumatic and Musculoskeletal Disease Unit, Our Lady's Hospice and Care Services, Dublin, Ireland.
⁹ Department of Rheumatology, University College London Hospital, London.
¹⁰ Department of Rheumatology, Aneurin Bevan University Health Board, Newport, UK.
¹¹ Department of Rheumatology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
¹² Department of Rheumatology, Sandwell and West Birmingham Hospitals NHS Trust and Division of Immunity and Infection, University of Birmingham, Birmingham, UK.
¹³ Centre for Rheumatology Research, UCL Division of Medicine, University College London, London, Womens Health, University College London Hospital, London, i.giles@ucl.ac.uk.

No abstract available

Keywords: DMARDs; biologics; breastfeeding; corticosteroids; hydroxychloroquine; pregnancy; prescribing; rheumatic disease.

Publication types